Company Name, Ticker, Customers, else..

Abbvie inc (ABBV)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Abbvie inc

ABBV's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

ABBV Growth rates comparisons

Looking into Abbvie Inc growth rates, revenue grew by 1.58 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 2101

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.56 %

Abbvie Inc 's net profit deacreased by -38.89 % in IV. Quarter 2022 year on year, to $2,472 millions.

• More on ABBV's Growth

ABBV's Valuation comparisons

Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc PEG ratio is at 9.93 Abbvie Inc realized cash outflow of $ -0.31per share in trailing twelve-month period.

Company

24.08

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 4.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.

• More on ABBV's Valuation

Total Debt (Millions $)	63,271
Dividend TTM ($)	5.65 $
Dividend Yield TTM (%)	3.53 %
Revenue/Employee (TTM) $	1,161,080
Net Income/Employee (TTM) $	236,900
Receivable Turnover (TTM)	5.28
Tangible Book Value (Per Share $)	-46.11

ABBV's Valuation comparisons

Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbvie Inc PEG ratio is at 9.93 Abbvie Inc realized cash outflow of $ -0.31per share in trailing twelve-month period.

Company

24.08

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 4.9.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.

Abbvie Inc Price to Book Ratio is at 16.46 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on ABBV's Valuation

• Market Capitalization (Millions $)	284,510
• Shares Outstanding (Millions)	1,785
• Employees	50,000
• Revenues (TTM) (Millions $)	58,054
• Net Income (TTM) (Millions $)	11,845
• Cash Flow (TTM) (Millions $)	-545
• Capital Exp. (TTM) (Millions $)	-695
• Total Debt (Millions $)	63,271
• Dividend TTM ($)	5.65 $
• Dividend Yield TTM (%)	3.53 %
• Revenue/Employee (TTM) $	1,161,080
• Net Income/Employee(TTM) $	236,900
• Receivable Turnover Ratio (TTM)	5.28
• Tangible Book Value (Per Share $)	-46.11

• Market Capitalization (Millions $)	284,510
• Shares Outstanding (Millions)	1,785
• Employees	50,000
• Revenues (TTM) (Millions $)	58,054
• Net Income (TTM) (Millions $)	11,845
• Cash Flow (TTM) (Millions $)	-545
• Capital Exp. (TTM) (Millions $)	-695

ABBV's Profitability Comparisons

Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 36.39 % from 31.08 % in III. Quarter.

Abbvie Inc net profit margin of 16.35 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1022 in S&P 500.

Profitability by Segment

	*Ratio*
• Capital Ratio (MRQ)	0.96
• Total Debt to Equity (MRQ)	3.66
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.41
• Inventory Turnover Ratio (TTM)	5.11

ABBV's Profitability Comparisons

Abbvie Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 36.39 % from 31.08 % in III. Quarter.

Abbvie Inc net profit margin of 16.35 % is currently ranking no. 47 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1022 in S&P 500.

• More on ABBV's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar AYRO's Profile Stock Price AYRO's Financials Business Description Fundamentals Charts & Quotes AYRO's News Suppliers AYRO's Competitors Customers & Markets Economic Indicators AYRO's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071